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From three endemic locations of erythema chronicum migrans disease in North Rhine-
Westphalia, Germany, we recovered 19 isolates of a spirochete from Ixodes ricinus ticks. The
infection rate in adult ticks was 16 percent. The isolated spirochete is immunologically related
to the Ixodes dammini spirochete, Borrelia duttoni, and Treponemapallidum. Using indirect
immunofluorescence, the sera of90 patients with erythema chronicum migrans disease showed
antibody titers against the isolated spirochete, which correlated with the clinical course.
Similarly, antibodies were demonstrated in the sera of21 patients with acrodermatitis chronica
atrophicans. These results suggest an etiologic role for the Ixodes ricinus spriochete in Euro-
pean erythema chronicum migrans disease.
Erythema chronicum migrans, a unique skin lesion, was first recognized in 1910
[1]. During subsequent years, particularly after effective therapy with penicillin was
reported in 1951 [2], the disease was generally thought to be a harmless skin disease.
The skin lesion was not connected to involvement ofthe nervous system because the
erythema was often absent or missed [3]. Involvement ofjoints and heart, which are
rare in Europe, was not recognized at all [4,5]. Also generally not considered was the
possibility that acrodermatitis chronica atrophicans might be a late manifestation of
the same disease.
The observation of bites of ticks and other arthropods, seasonal occurrence, in-
flammatory signs, phasic course, and the successful transmission of the erythema
from man to man [6] supported the concept that these were infectious diseases
transmitted by arthropods. However, a number of incriminated agents could not be
confirmed, as was not the microscopic finding ofspirochetes by Lennoffin 1948 [7].
The reported transmission by ticks, the proven sensitivity to penicillin or
tetracycline [8], and the finding oflocally synthesized IgM in cerebrospinal fluid [9],
as in neurosyphilis, suggested that the causative agent might be a spirochete related
to Borrelia duttoni, the causative agent of tick-borne relapsing fever. We were able
to confirm this hypothesis by the demonstration of rising IgM and IgG antibody
titers against Borrelia duttoni in sera and cerebrospinal fluid of patients with
erythema chronicum migrans (Fig. 1) [10].
In the United States, the spirochetal etiology of Lyme disease was established by
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the isolation of a spirochete from Ixodes dammini, by the demonstration of an-
tibodies against the new agent in the sera of patients with Lyme disease [11], and
finally by the isolation ofthe same spirochete from the skin, blood, and spinal fluid
of patients [12,13]. Burgdorfer et al. (1983) reported the isolation of a spirochete
from Ixodes ricinus from Switzerland that was morphologically and immunologi-
cally nearly indistinguishable from the Ixodesdamminispirochete [14]. This finding
suggested that an identical pathogenic agent might be responsible for both diseases.
The close relationship between the North American and the European disease was
also shown by the demonstration of antibodies against the Ixodes dammini
spirochete in the sera of six of nine patients with erythema chronicum migrans me-
ningopolyneuritis from Sweden [15]. We confirmed this finding. Thirty-four of our
39 patients with antibodies (2 1:128) against Borrelia duttoni also had antibodies
against the Ixodes dammini spirochete [16].
We report here the isolation of a spirochete from Ixodes ricinus in Germany,
similar to the Ixodes dammini spirochete. Extensive antibody studies support the
hypotheses ofan etiologic role for this agent in erythema chronicum migrans disease
[16].
METHODS
Ixodes ricinus ticks were obtained by flagging in three endemic locations for tick-
borne meningopolyneuritis in North Rhine-Westphalia. Specimens of the internal
organs of the ticks were cultivated in a modified Kelly's medium [12]. Indirect im-
munofluorescence was done by standard methods.
RESULTS
We recovered 19 isolates of spirochetes from Ixodes ricinus ticks from three
separate endemic locations of erythema chronicum migrans in North Rhine-
Westphalia (Table 1). The infection rate in adult ticks was 16 percent, lower than
that in Switzerland (36 percent), but similar to that ofendemic areas ofLyme disease
in southeastern Connecticut. According to the history of our patients, two of the
locations must have already been endemic 13 and 19 years ago.
By indirect immunofluorescence, sera from American and European patients
revealed similar antibody titers against the isolated spirochete and the Ixodes dam-
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TABLE 1
Isolation of Spirochetes from I. ricinus from Endemic Locations for
Erythema Chronicum Migrans Disease in North Rhine-Westphalia
I. ricinus
Endemic Location Adults Nymphs
Huertgen 3/13a 8/20b
Koenigsforst 3/18
Bad Honnef 1/12 5/5
Total 7/43 13/25
aIsolates/investigated ticks
'Isolates/investigated pools [10]
TABLE 2
I. ricinus and I. dammini Spirochete: Immunologic Comparison
Spirochete
Serum I. ricinus I. dammini
Polyclonal antibody
Meningopolyneuritis, patient SM > 1024 512
Lyme disease, patient EP > 1024 > 1024
Normal human serum <32 <32
Monoclonal antibody
Mouse monoclonal antibody <32 256
Normal mouse serum <32 <32
mini spirochete. In contrast, a monoclonal antibody against the Ixodes dammini
spirochete, provided by Dr. A.G. Barbour, did not react with the Ixodes ricinus
spirochete (Table 2).
Serum from patients with syphilis, Lyme disease, and erythema chronicum
migrans meningopolyneuritis reacted with the Ixodes ricinus and Ixodes dammini
spirochetes as well as with Borrelia duttoni and Treponema pallidum. Absorption
with Treponemaphagedenis antigen diminished thereactions, especiallythose ofthe
syphilis serum (Fig. 2).
Electron microscopy of the spirochete isolated from Ixodes ricinus revealed a
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FIG. 2. I. ricinus spiro-
chete: Antibody titers be-
fore and after absorption
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FIG. 3. Electron micrographs of the L ricinus
spirochete. The spirochetes had a transverse
diameter of about 0.2 Im, a length of 8.8 to 33
Aom, and 12 to 14 flagellae. The organism is seen
in longitudinal section (rightpanel) and in cross
section (left panel).
diameter of 0.2 Am and a length of 8.8 to 33 Am. The spirochete showed 12 to 14
flagellae, apparently more than the Ixodes dammini spirochete and the Ixodes
ricinus spirochete from Switzerland (Fig. 3) [14].
The antibody response ofpatients with erythema chronicum migrans disease cor-
related with the clinical course. One patient with erythema alone who was treated
with penicillin showed a fourfold decrease in the IgG antibody titer between acute
disease and convalescence. Another patient who did not receive penicillin therapy
developed meningopolyneuritis. This patient had a fourfold rise in titer between the
fifth and tenth weeks followed by a slow decrease after three months. Concomitant
cerebrospinal fluid showed an IgG antibody titer as high as 1:64 followed by a four-
fold decrease. Both patients had only minimal specific IgM antibody (Fig. 4).
Comparison of antibody titers in patients and controls revealed high levels in pa-
tients. Of 39 patients with erythema chronicum migrans alone, 50 percent of those
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FIG. 4. Erythema chronicum migrans alone (A) and tick-borne meningopoly-
neuritis (B): Clinical course and corresponding antibody titers against the I. ricinus
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FIG. 5. Antibody titers against the I. ricinus spirochete in serum samples from 90 patients
with erythema chronicum migrans (ECM) disease.
treated with antibiotics showed antibody titers of 1:64 or higher against the Ixodes
ricinus spirochete. In contrast, 90 percent of 51 patients with meningopolyneuritis
who did not receive antibiotic therapy had elevated titers. In these groups, 20 per-
cent and 68 percent, respectively, had IgM antibody titers of 1:32 or higher (Fig. 5).
Cerebrospinal fluids showed IgG antibody titers as high as 1:64 (Fig. 6).
Fourfold rises or decreases of IgG or IgM antibodies could be demonstrated in 50
cases. Rises generally occurred between the third and the sixth week after the onset
ofthe disease. Fourfold changes ofspecific IgG antibody in cerebrospinal fluid were
seen in 22 cases (Fig. 7).
The first example ofalate complication is the demonstration ofantibodies against
the Ixodes ricinus spirochete in patients with acrodermatitis chronica atrophicans.
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FIG. 6. Titers against the I. ricinus spirochete in CSF from 27 patients with tick-
borne meningopolyneuritis.
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FIG. 7. Antibody titers against the I. ricinus spirochete in paired serum samples from patients with
erythema chronicum migrans (ECM) disease.
This chronic skin disease, which occurs in Europe [17], is presumed to be transmit-
ted byIxodesricinus and isthought to be related to erythema chronicum migrans. In
the first phase of the disease, the skin lesion becomes red, blue, and edematous.
During the second phase, it atrophies and becomes extremely thin, like cigarette
paper. The disease usually begins in the peripheral part of one extremity, but later
0,5-ly 2-5y 8-35y c1 2 713y
after thera:py
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FIG. 8. IgG (a) and IgM (0) antibody titers against the I. ricinus spirochete in 21 patients
with acrodermatitis chronica atrophicans (y = years after onset).
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can involve all four extremities. All 21 of our patients with acrodermatitis chronica
atrophicans had elevated IgG antibody titers against the Ixodes ricinus spirochete
(Fig. 8). Although acrodermatitis chronica atrophicans can be treated with
penicillin, a fourfold decrease in antibody titers could as yet be demonstrated in only
two patients.
DISCUSSION
The spirochete isolated from Ixodes ricinus in three endemic areas in North
Rhine-Westphalia seems to be the etiologic agent of European erythema chronicum
migrans disease. Immunologically the agent is closely related to Borrelia duttoniand
the etiologic agent of Lyme disease. Further studies will show whether there are dif-
ferent strains of Ixodes ricinus spirochetes. Nevertheless, the diseases on the two
continents differ in some respects. In general, European erythema chronicum
migrans disease is less severe than Lyme disease. Multiple erythemas, joint and heart
involvement, and recurrences of meningopolyneuritis are rare or unknown in
Europe.
The antibody response, which correlated with the clinical course of 90 patients
with erythema chronicum migrans disease, also indicates an etiologic role for the Ix-
odesricinus spirochete, although for definitive proofthe spirochete must be isolated
from man. Even so, antibody tests have already enabled us to clarify the diagnosis in
questionable cases of erythema chronicum migrans disease. Although they are cur-
rently unknown, it is possible that late clinical manifestaitons of the spirochetosis
may come to light, similar to the late stages of syphilis.
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